• The CRISPR Data Platform for Diagnostics

  • Our vision

    We are creating the next generation diagnostics platform using CRISPR technology.

    Rapid Diagnostic Tools

    Fast, low cost, and easy to use.

    Our CRISPR based system returns a result within one hour and does not require expensive equipment or electricity.

    Massively Parallel Diagnostic Development

    The CRISPR Platform for Diagnostic Development

    By leveraging the ability to screen hundreds of thousands of CRISPR guides at once we can develop hundreds of potential diagnostics in parallel. The nature of CRISPR tech changes the fundamental business economics and operational approach of a diagnostics company.

  • Diagnostic Fields

    Oil and Gas Industry

    e.g. Microbial Induced Corrosion


    e.g. Strep Throat, TB, HPV, EB


    e.g. Bovine TB, Pathogenic Fungi & Microorganisms


    e.g. DNA Typing

  • Founding Team

    Together we have over 10 years of experience in computational and molecular biology.

    Trevor Martin

    Co-Founder, CEO

    PhD, Stanford University

    Ashley Tehranchi

    Co-Founder, CSO

    PhD, Stanford University

  • We're Hiring!

    Join us in revolutionizing the diagnostic industry. Send your resume to careers@mammothdiagnostics.com

    Molecular Biology Team - Research Scientist

    • Develop high throughput CRISPR based assays. 
    • Opportunity to work with liquid handling robotics. 
    • Experimental evolution of CRISPR proteins. 

    Bioinformatics Team - Data Scientist

    • Design CRISPR guides for use in high throughput screens. 
    • Develop machine learning tools to optimize CRISPR guide design based on high throughput screens. 
    • Build large databases. 

    Molecular Biology Team - Research Scientist

    • Develop sample preparation chemistry. 
    • Design high throughput assays of reagent chemistries. 
    • Opportunity to work with clinical samples. 

    Management Team - FDA Regulation Specialist

    • Coordinate with the FDA to help bring CRISPR diagnostics to the healthcare industry. 
    • Execute clinical trials for in vitro diagnostic targets. 
    • Manage processes for CLIA and 510(k) compliance and certification. 
  • Press

    Palo Alto, Calif. – September 12, 2017 – Mammoth Diagnostics today announced that it will purchase oligo pools from Twist Bioscience to develop a new class of sequence-based diagnostics.   “Using comprehensive oligo pools from Twist Bioscience, we are able to quickly screen millions of unique...
  • Connect With Us

    3060 Coronado Dr., Santa Clara, 95054
    All Posts